We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
+21.9%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$57.6B
AUM Growth
+$7.69B
(+15%)
Cap. Flow
+$3.7B
Cap. Flow
% of AUM
6.42%
Top 10 Holdings %
Top 10 Hldgs %
40.22%
Holding
1,054
New
202
Increased
277
Reduced
473
Closed
81
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America Series L
BAC.PRL
|
+$3.4B |
| 2 |
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
|
+$885M |
| 3 |
Tesla
TSLA
|
+$252M |
| 4 |
Amazon
AMZN
|
+$156M |
| 5 |
CLVT.PRA
Clarivate Plc 5.25% Series A Mandatory Convertible Preferred Shares
CLVT.PRA
|
+$144M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$379M |
| 2 |
Sherwin-Williams
SHW
|
+$161M |
| 3 |
NVIDIA
NVDA
|
+$154M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$116M |
| 5 |
Boeing
BA
|
+$80M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.6% |
| 2 | Consumer Discretionary | 15.59% |
| 3 | Communication Services | 15.36% |
| 4 | Healthcare | 13.38% |
| 5 | Financials | 10.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Credicorp
BAP
$30.4B
| $5.15M | 0.01% |
38,878
+8,430
| +28% | +$1.13M |
|
377
Custom Truck One Source
CTOS
$2.42B
| $5.12M | 0.01% |
753,871
-5,302
| -0.7% | -$36.8K |
|
378
HDFC Bank
HDB
$120B
| $5.1M | 0.01% |
152,972
-59,168
| -28% | -$1.98M |
|
379
VSE Corp
VSEC
$6.21B
| $5.09M | 0.01% |
113,437
-2,211
| -2% | -$112K |
|
|
PSTL
380
Postal Realty Trust
PSTL
$680M
| $4.99M | 0.01% |
327,962
-6,960
| -2% | -$104K |
|
381
Merck
MRK
$323B
| $4.94M | 0.01% |
46,449
-3,394
| -7% | -$366K |
|
382
Utah Medical Products
UTMD
$227M
| $4.88M | 0.01% |
51,520
-884
| -2% | -$81.3K |
|
383
Pure Cycle
PCYO
$270M
| $4.86M | 0.01% |
514,293
-9,836
| -2% | -$90.6K |
|
384
Walmart Inc
WMT
$897B
| $4.7M | 0.01% |
95,556
+1,806
| +2% | +$85.7K |
|
385
NextEra Energy
NEE
$177B
| $4.54M | 0.01% |
58,852
+918
| +2% | +$70.6K |
|
386
iShares Russell 1000 Growth ETF
IWF
$127B
| $4.43M | 0.01% |
72,532
-113,772
| -61% | -$6.55M |
|
387
ANI Pharmaceuticals
ANIP
$1.74B
| $4.13M | 0.01% |
+104,012
| New | +$4.39M |
|
388
Elevance Health
ELV
$86.2B
| $4.06M | 0.01% |
8,825
+312
| +4% | +$148K |
|
389
American Tower
AMT
$78.8B
| $4.01M | 0.01% |
19,627
+1,242
| +7% | +$261K |
|
390
Abbott
ABT
$188B
| $3.94M | 0.01% |
38,914
+1,041
| +3% | +$110K |
|
391
Morgan Stanley
MS
$338B
| $3.56M | 0.01% |
40,591
+462
| +1% | +$43.1K |
|
|
NXDT
392
NexPoint Diversified Real Estate Trust
NXDT
$245M
| $3.54M | 0.01% |
341,417
| – | – |
|
393
Thermo Fisher Scientific
TMO
$222B
| $3.5M | 0.01% |
6,073
+149
| +3% | +$84K |
|
394
Union Pacific
UNP
$174B
| $3.41M | 0.01% |
16,963
-29
| -0.2% | -$5.88K |
|
395
Vanguard Morningstar Growth ETF
VUG
$230B
| $3.28M | 0.01% |
78,942
-1,557,540
| -95% | -$60.6M |
|
396
Duke Energy
DUK
$94.5B
| $3.24M | 0.01% |
33,599
-498
| -1% | -$49.2K |
|
397
Bristol-Myers Squibb
BMY
$132B
| $3.23M | 0.01% |
46,652
-8,171
| -15% | -$576K |
|
398
Newmont
NEM
$124B
| $3.21M | 0.01% |
65,488
-609
| -0.9% | -$29.5K |
|
399
Williams Companies
WMB
$87.9B
| $3.09M | 0.01% |
103,525
-421
| -0.4% | -$13K |
|
400
Invesco Senior Loan ETF
BKLN
$6.74B
| $2.99M | 0.01% |
143,760
-115,619
| -45% | -$2.42M |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q1 2023 Portfolio in Review
As of Q1 2023, Loomis, Sayles & Company held 1,054 positions worth $57.6B, up 15% from $49.9B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Loomis, Sayles & Company deployed $3.7B of net new capital in Q1 2023, opening 202 new positions and adding to 277 existing holdings. Its largest new stake was Bank of America Series L: 2,835,020 shares worth $81.1M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Communication Services.
On the sell side, the largest reduction was Novartis, an estimated $379M trimmed.
- Loomis, Sayles & Company's largest Q1 2023 buy was Bank of America Series L: 2,835,020 shares worth $81.1M.
- Loomis, Sayles & Company added most to Tesla in Q1 2023, an estimated $252M increase.
- Loomis, Sayles & Company's biggest Q1 2023 reduction was Novartis, cutting an estimated $379M.
- Loomis, Sayles & Company fully exited Globus Medical in Q1 2023, selling an estimated $38M.
- Loomis, Sayles & Company's ten largest holdings make up 40% of its $57.6B portfolio in Q1 2023.
- Loomis, Sayles & Company opened 202 new positions and closed 81 in Q1 2023.
- Loomis, Sayles & Company's portfolio value rose 15% quarter-over-quarter to $57.6B.
Based on Loomis, Sayles & Company's 13F filing for Q1 2023, filed 11 May 2023.